Share on LinkedInShare on LinkedIn

ARTICLE · 28 JANUARY 2025

EU Directive on Liability for Defective Products: implications for medical device producers in Australia

Corrs Chambers Westgarth
Corrs Chambers Westgarth
Contributor
Corrs Chambers Westgarth

Corrs Chambers Westgarth

Corrs Chambers Westgarth is Australia’s leading independent law firm. We provide exceptional legal...

View firm profile
Explore more from Corrs Chambers Westgarth

Directive provides a timely warning to Australian manufacturers to review their medical and pharmaceutical product standards.

AustraliaConsumer Protection

A new EU Directive could have widespread implications for Australian manufacturers of medical and pharmaceutical products supplied within the EU. The Directive significantly lowers the bar for the bringing of legal claims that increases the risk of Australian manufacturers being sued in the EU.

The Directive provides a timely warning to Australian manufacturers to review their medical and pharmaceutical product standards and ensure they are protected against the increased risk.

Background

On 8 December 2024, the new product liability Directive (Directive (EU) 2024/2853) adopted by the Council of the European Union on 10 October 2024 came into force. Member States are required to transpose the Directive into national law within two years.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

    Lawyers Weekly Law firm of the year 2021                  
Employer of Choice for Gender Equality (WGEA)

See more popular content from